| Acute (n = 28) | Chronic (n = 22) | Controller (n = 6) |
---|---|---|---|
Age, years | 40.6 ± 9.1 | 43.7 ± 8.1 | 35.8 ± 5.0 |
Male/Female | 27/1 | 18/4 | 5/1 |
Race/Ethnicity | Â | Â | Â |
African-American | 3 | 3 | 2 |
Caucasian | 23 | 16 | 3 |
Haitian | 0 | 1 | 0 |
Latino/Hispanic | 2 | 2 | 1 |
Duration of infection, monthsa | 23 ± 13 | 122 ± 58 | 137 ± 83 |
[range] | [1 – 49] | [30 – 191] | [16 – 241] |
CD4 + T cells, cells × 10 6 /ml a | 675 ± 239 | 546 ± 236 | 615 ± 285 |
[range] | [253 – 1252] | [89 – 828] | [176 – 1000] |
Mean plasma HIV-1 RNA, log10 copies/ml | 3.99 | 4.13 | 2.03 |
[range] | [1.70 – 5.27] | [1.70 – 4.99] | [1.70 – 2.60] |
Receiving antiretroviral therapy b | Â | Â | Â |
Yes (%) | 57 % | 59 % | 0 % |
No (%) | 43 % | 41 % | 100 % |